What’s on the horizon for nonalcoholic steatohepatitis (NASH) treatment?
The future of NASH treatment is more promising than ever with improved methods for diagnosis and new drugs in development.
Read More
Evernorth Announces Industry-First Financial Guarantee For GLP-1 Spend
EncircleRx solution now includes financial predictability for health plan sponsors to help expand access for appropriate patients.
Read More
How Accredo’s physician engagement team simplifies the experience for prescribers
The team focuses on highly complex medications, including treatments for cancer, neurological diseases, pulmonary conditions, and bleeding disorders.
Read More
The importance of a clinical-first approach to formulary development
The clinical efficacy of a drug must always take priority over any other considerations when developing formularies.
Read More
Enhancing recruitment for local clinical drug trials
During the panel, experts discussed ways they have navigated patient recruitment challenges.
Read More
How a specialty pharmacy can help support patients that utilize copay assistance
The complex nature of copay assistance programs requires operational agility on the part of specialty pharmacies.
Read More